FDA OKs Benralizumab for Asthma in Children as Young as 6 Years
Pediatric News ,
Benralizumab is now approved by the US Food and Drug Administration (FDA) for the treatment of asthma in children older than 6…
Benralizumab is now approved by the US Food and Drug Administration (FDA) for the treatment of asthma in children older than 6…
Benralizumab ahora está aprobado por la Administración de Drogas y Alimentos de EE.
The FDA has approved benralizumab (Fasenra) for children aged 6 to 11 years with severe eosinophilic asthma, according to an…
The FDA has approved benralizumab (Fasenra; AstraZeneca) as an add-on therapy when treating patients aged 6 to 11 years that…